Consequently, all the above guidelines recommend that the following should be assessed before starting treatment: stage of liver disease; HBV DNA concentration and ALT level; HBeAg status; family history of hepatocellular carcinoma, co-infection with HIV and other liver diseases. The gene discussed is GPT; the disease is liver disorder.